EDAP TMS S.A. American Depositary Shares (FOCL) Stock Analysis & Investment Frameworks

EDAP TMS S.A. American Depositary Shares (FOCL) stock analysis on Invetso. Review EDAP TMS S.A. American Depositary Shares’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

EDAP TMS S.A. American Depositary Shares Company Overview

EDAP TMS S.A. American Depositary Shares Key Financial Metrics

About EDAP TMS S.A. American Depositary Shares

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

EDAP TMS S.A. American Depositary Shares Investment Frameworks

Invetso analyzes EDAP TMS S.A. American Depositary Shares (FOCL) across the following frameworks:

Explore More FOCL Research